Claes Göran Tropé

Bilde av person
Kan ikke hente personopplysninger fra ekstern kilde

Publikasjoner

  • Solheim, Olesya; Skalleberg, Jakob Rasmussen; Warncke, Torhild; Ørstavik, Kristin; Tropé, Claes Gøran & Fosså, Sophie Dorothea (2019). Long‐term neurotoxicity and Raynaud's phenomenon in patients treated with cisplatin‐based chemotherapy for malignant ovarian germ cell tumor. Acta Obstetricia et Gynecologica Scandinavica. ISSN 0001-6349. 98(2), s. 240–249. doi: 10.1111/aogs.13477. Fulltekst i vitenarkiv
  • Wang, Zhihui; Førsund, Mette S; Tropé, Claes Gøran; Nesland, Jahn M; Holm, Ruth & Slipicevic, Ana (2018). Evaluation of CHK1 activation in vulvar squamous cell carcinoma and its potential as a therapeutic target in vitro. Cancer Medicine. ISSN 2045-7634. 7(8), s. 3955–3964. doi: 10.1002/cam4.1638. Fulltekst i vitenarkiv
  • Agostini, Antonio; Brunetti, Marta; Davidson, Ben; Tropé, Claes Gøran; Heim, Sverre & Panagopoulos, Ioannis [Vis alle 7 forfattere av denne artikkelen] (2018). Identification of novel cyclin gene fusion transcripts in endometrioid ovarian carcinomas. International Journal of Cancer. ISSN 0020-7136. 143(6), s. 1379–1387. doi: 10.1002/ijc.31418. Fulltekst i vitenarkiv
  • Szczesny, Witold; Langseth, Hilde; Myklebust, Tor Åge; Kærn, Janne; Tropé, Claes Gøran & Paulsen, Torbjørn (2018). Survival after secondary cytoreductive surgery and chemotherapy compared with chemotherapy alone for first recurrence in patients with platinum-sensitive epithelial ovarian cancer and no residuals after primary treatment. A registry-based study. Acta Obstetricia et Gynecologica Scandinavica. ISSN 0001-6349. 97(8), s. 956–965. doi: 10.1111/aogs.13361.
  • Agostini, Antonio; Brunetti, Marta; Davidson, Ben; Tropé, Claes Gøran; Eriksson, Ane Gerda Zahl & Heim, Sverre [Vis alle 8 forfattere av denne artikkelen] (2018). The microRNA miR-192/215 family is upregulated in mucinous ovarian carcinomas. Scientific Reports. ISSN 2045-2322. 8. doi: 10.1038/s41598-018-29332-7. Fulltekst i vitenarkiv
  • Onallah, Hadil; Catane, Liora Jacobs; Tropé, Claes Gøran; Falkenthal, Thea Eline Hetland; Reich, Reuven & Davidson, Ben (2018). Activity and clinical relevance of autotaxin and lysophosphatidic acid pathways in high-grade serous carcinoma. Virchows Archiv. ISSN 0945-6317. doi: 10.1007/s00428-018-2418-x. Fulltekst i vitenarkiv
  • Davidson, Ben; Holth, Arild; Wang, Zhihui; Hellesylt, Ellen; Tropé, Claes Gøran & Falkenthal, Thea Eline Hetland [Vis alle 7 forfattere av denne artikkelen] (2018). Expression of 14-3-3 sigma and eta proteins is unrelated to survival in metastatic high-grade serous carcinoma. APMIS - Journal of Pathologiy, Microbiology and Immunology. ISSN 0903-4641. 126(4), s. 309–313. doi: 10.1111/apm.12816.
  • Filippov-Levy, Natalie; Cohen-Schussheim, Hallel; Tropé, Claes Gøran; Falkenthal, Thea Eline Hetland; Smith, Yoav & Davidson, Ben [Vis alle 7 forfattere av denne artikkelen] (2018). Expression and clinical role of long non-coding RNA in high-grade serous carcinoma. Gynecologic Oncology. ISSN 0090-8258. 148(3), s. 559–566. doi: 10.1016/j.ygyno.2018.01.004.
  • Popova, Olesya; Førsund, Mette S; Tropé, Claes Gøran; Kraggerud, Sigrid M.; Nesland, Jahn M & Davidson, Ben (2017). Epithelial-mesenchymal transition markers in malignant ovarian germ cell tumors. APMIS - Journal of Pathologiy, Microbiology and Immunology. ISSN 0903-4641. 125(9), s. 781–786. doi: 10.1111/apm.12715.
  • Smebye, Marianne Lislerud; Agostini, Antonio; Johannessen, Bjarne; Thorsen, Jim; Davidson, Ben & Tropé, Claes Gøran [Vis alle 9 forfattere av denne artikkelen] (2017). Involvement of DPP9 in gene fusions in serous ovarian carcinoma. BMC Cancer. ISSN 1471-2407. 17(1). doi: 10.1186/s12885-017-3625-6.
  • Meltzer-Gunnes, Christin Julia; Småstuen, Milada C; Kristensen, Gunnar S Balle; Tropé, Claes Gøran; Lie, Agnes Kathrine & Vistad, Ingvild (2017). Vulvar carcinoma in Norway: A 50-year perspective on trends in incidence, treatment and survival. Gynecologic Oncology. ISSN 0090-8258. 145(3), s. 543–548. doi: 10.1016/j.ygyno.2017.03.008.
  • Agostini, Antonio; Brunetti, Marta; Davidson, Ben; Tropé, Claes Gøran; Heim, Sverre & Panagopoulos, Ioannis [Vis alle 7 forfattere av denne artikkelen] (2017). Genomic imbalances are involved in miR-30c and let-7a deregulation in ovarian tumors: Implications for HMGA2 expression. OncoTarget. ISSN 1949-2553. 8(13), s. 21554–21560. doi: 10.18632/oncotarget.15795.
  • Gutgold, N.; Davidson, Ben; Catane, Liora Jacobs; Holth, Arild; Hellesylt, Ellen & Tropé, Claes Gøran [Vis alle 8 forfattere av denne artikkelen] (2017). TGF? splicing and canonical pathway activation in high-grade serous carcinoma. Virchows Archiv. ISSN 0945-6317. 470, s. 665–678. doi: 10.1007/s00428-017-2127-x.
  • Brunetti, Marta; Agostini, Antonio; Davidson, Ben; Tropé, Claes Gøran; Heim, Sverre & Panagopoulos, Ioannis [Vis alle 7 forfattere av denne artikkelen] (2017). Recurrent fusion transcripts in squamous cell carcinomas of the vulva. OncoTarget. ISSN 1949-2553. 8(10), s. 16843–16850. doi: 10.18632/oncotarget.15167.
  • Harel-Dassa, Keren; Yedgar, Saul; Tropé, Claes Gøran; Davidson, Ben & Reich, Reuven (2017). Phospholipase D messenger RNA expression and clinical role in high-grade serous carcinoma. Human Pathology. ISSN 0046-8177. 62, s. 115–121. doi: 10.1016/j.humpath.2016.12.023.
  • Broner, Esther Channah; Tropé, Claes Gøran; Reich, Reuven & Davidson, Ben (2017). TSAP6 is a novel candidate marker of poor survival in metastatic high-grade serous carcinoma. Human Pathology. ISSN 0046-8177. 60, s. 180–187. doi: 10.1016/j.humpath.2016.10.017.
  • Smebye, Marianne Lislerud; Haugom, Lisbeth; Davidson, Ben; Tropé, Claes Gøran; Heim, Sverre & Skotheim, Rolf I. [Vis alle 7 forfattere av denne artikkelen] (2017). Bilateral ovarian carcinomas differ in the expression of metastasis-related genes. Oncology Letters. ISSN 1792-1074. 13(1), s. 184–190. doi: 10.3892/ol.2016.5384.
  • Yu, Dandan; Holm, Ruth; Goscinski, Mariusz Adam; Tropé, Claes Gøran; Nesland, Jahn M & Suo, Zhenhe (2016). Prognostic and clinicopathological significance of Cacna2d1 expression in epithelial ovarian cancers: a retrospective study. American Journal of Cancer Research. ISSN 2156-6976. 6(9), s. 2088–2097.
  • LI, Yaqing; Huang, Ruixia; Li, Xiaoli; Li, Xiaoran; Yu, Dandan & Zhang, Mingzhi [Vis alle 11 forfattere av denne artikkelen] (2016). Decreased expression of pyruvate dehydrogenase A1 predicts an unfavorable prognosis in ovarian carcinoma. American Journal of Cancer Research. ISSN 2156-6976. 6(9), s. 2076–2087.
  • Agostini, Antonio; Brunetti, Marta; Davidson, Ben; Tropé, Claes Gøran; Heim, Sverre & Panagopoulos, Ioannis [Vis alle 7 forfattere av denne artikkelen] (2016). Expressions of miR-30c and let-7α are inversely correlated with HMGA2 expression in squamous cell carcinoma of the vulva. OncoTarget. ISSN 1949-2553. 7(51), s. 85058–85062. doi: 10.18632/oncotarget.13187.
  • Horwitz, Vered; Davidson, Ben; Stern, Dganit; Tropé, Claes Gøran; Re'Em, Tali Tavor & Reich, Reuven (2016). Ezrin is associated with disease progression in ovarian carcinoma. PLOS ONE. ISSN 1932-6203. 11(9). doi: 10.1371/journal.pone.0162502.
  • Makar, Amin P.; Tropé, Claes Gøran; Tummers, Philippe; Denys, Hannelore & Vandecasteele, Katrien (2016). Advanced ovarian cancer: Primary or interval debulking? Five categories of patients in view of the results of randomized trials and tumor biology: Primary debulking surgery and interval debulking surgery for advanced ovarian cancer. The Oncologist. ISSN 1083-7159. 21(6), s. 745–754. doi: 10.1634/theoncologist.2015-0239.
  • Agostini, Antonio; Panagopoulos, Ioannis; Davidson, Ben; Tropé, Claes Gøran; Heim, Sverre & Micci, Francesca (2016). A novel truncated form of HMGA2 in tumors of the ovaries. Oncology Letters. ISSN 1792-1074. 12(2), s. 1559–1563. doi: 10.3892/ol.2016.4805.
  • Szczesny, Witold; Vistad, Ingvild; Kærn, Janne; Nakling, Ole Jakob; Tropé, Claes Gøran & Paulsen, Torbjørn (2016). Impact of hospital type and treatment on long-term survival among patients with FIGO Stage IIIC epithelial ovarian cancer: Follow-up through two recurrences and three treatment lines in search for predictors for survival. European Journal of Gynaecological Oncology. ISSN 0392-2936. 37(3), s. 305–311. doi: 10.12892/ejgo3007.2016.
  • Nymoen, Dag Andre; Slipicevic, Ana; Holth, Arild; Emilsen, Elisabeth; Falkenthal, Thea Eline Hetland & Tropé, Claes Gøran [Vis alle 9 forfattere av denne artikkelen] (2016). Mir-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinoma. Human Pathology. ISSN 0046-8177. 54, s. 74–81. doi: 10.1016/j.humpath.2016.03.010.
  • Davidson, Ben; Holth, Arild; Hellesylt, Ellen; Hadar, Rivka; Katz, Betina & Tropé, Claes Gøran [Vis alle 7 forfattere av denne artikkelen] (2016). HUR mRNA expression in ovarian high-grade serous carcinoma effusions is associated with poor survival. Human Pathology. ISSN 0046-8177. 48, s. 95–101. doi: 10.1016/j.humpath.2015.09.027.
  • Nymoen, Dag Andre; Holth, Arild; Hetland, Thea Eline; Tropé, Claes Gøran & Davidson, Ben (2015). CIAPIN1 and ABCA13 are markers of poor survival in metastatic ovarian serous carcinoma. Molecular Cancer. ISSN 1476-4598. 14:44, s. 1–9. doi: 10.1186/s12943-015-0317-1.
  • Bartlett, Thomas E.; Jones, Alison; Goode, Ellen L.; Fridley, Brooke L.; Cunningham, Julie M. & Berns, Els M.J.J. [Vis alle 13 forfattere av denne artikkelen] (2015). Intra-gene DNA methylation variability is a clinically independent prognostic marker in women's cancers. PLOS ONE. ISSN 1932-6203. 10:e0143178(12). doi: 10.1371/journal.pone.0143178.
  • Teschendorff, Andrew E.; Lee, Shih-Han; Jones, Allison; Fiegl, Heidi; Kalwa, Marie & Wagner, Wolfgang [Vis alle 29 forfattere av denne artikkelen] (2015). HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer. Genome Medicine. ISSN 1756-994X. 7:108. doi: 10.1186/s13073-015-0233-4.
  • Nymoen, Dag Andre; Falkenthal, Thea Eline Hetland; Holth, Arild; Ow, Ghim Siong; Ivshina, Anna V. & Tropé, Claes Gøran [Vis alle 9 forfattere av denne artikkelen] (2015). Expression and clinical role of chemoresponse-associated genes in ovarian serous carcinoma. Gynecologic Oncology. ISSN 0090-8258. 139(1), s. 30–39. doi: 10.1016/j.ygyno.2015.07.107.
  • Katz, Betina; Tropé, Claes Gøran; Reich, Reuven & Davidson, Ben (2015). MicroRNAs in Ovarian Cancer. Human Pathology. ISSN 0046-8177. 46(9), s. 1245–1256. doi: 10.1016/j.humpath.2015.06.013.
  • Huang, Ruixia; Wang, Junbai; Zhong, Yali; Liu, Yishan; Stokke, Trond & Tropé, Claes Gøran [Vis alle 8 forfattere av denne artikkelen] (2015). Mitochondrial DNA deficiency in ovarian cancer cells and cancer stem cell-like properties. Anticancer Research. ISSN 0250-7005. 35(7), s. 3743–3754.
  • Huang, Ruixia; Li, Xiaoran; Holm, Ruth; Tropé, Claes Gøran; Nesland, Jahn M & Suo, Zhenhe (2015). The expression of aldehyde dehydrogenase 1 (ALDH1) in ovarian carcinomas and its clinicopathological associations: A retrospective study. BMC Cancer. ISSN 1471-2407. 15:502. doi: 10.1186/s12885-015-1513-5.
  • Wang, Zhihui; Slipicevic, Ana; Førsund, Mette S; Tropé, Claes Gøran; Nesland, Jahn M & Holm, Ruth (2015). Expression of CDK1Tyr15, pCDK1 Thr161, cyclin B1 (Total) and pCyclin B1 Ser126 in vulvar squamous cell carcinoma and their relations with clinicopatological features and prognosis. PLOS ONE. ISSN 1932-6203. 10(4). doi: 10.1371/journal.pone.0121398.
  • Agostini, Antonio; Panagopoulos, Ioannis; Andersen, Hege Kilen; Johannessen, Lene Elisabeth; Davidson, Ben & Tropé, Claes Gøran [Vis alle 8 forfattere av denne artikkelen] (2015). HMGA2 expression pattern and TERT mutations in tumors of the vulva. Oncology Reports. ISSN 1021-335X. 33(6), s. 2675–2680. doi: 10.3892/or.2015.3882.
  • Popova, Olesya; Tropé, Claes Gøran; Rokkones, Erik; Kærn, Janne; Paulsen, Torbjørn & Salvesen, Helga [Vis alle 9 forfattere av denne artikkelen] (2015). Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the "cisplatin era". Gynecologic Oncology. ISSN 0090-8258. 136(2), s. 224–229. doi: 10.1016/j.ygyno.2014.12.010.
  • Slipicevic, Ana; Holth, Arild; Hellesylt, Ellen; Tropé, Claes Gøran; Davidson, Ben & Flørenes, Vivi Ann (2014). Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions. . Gynecologic Oncology. ISSN 0090-8258. 135(1), s. 118–124. doi: 10.1016/j.ygyno.2014.07.102.
  • Davidson, Ben & Tropé, Claes Gøran (2014). Ovarian cancer: Diagnostic, biological and prognostic aspects. Women's Health.. ISSN 1745-5057. 10(5), s. 519–533. doi: 10.2217/whe.14.37.
  • Davidson, Ben; Holth, Arild; Hellesylt, Ellen; Tan, Tuan Zea; Huang, Ruby Yun-Ju & Tropé, Claes Gøran [Vis alle 8 forfattere av denne artikkelen] (2014). The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions. Human Pathology. ISSN 0046-8177. 46(1), s. 1–8. doi: 10.1016/j.humpath.2014.10.004.
  • Huang, Ruixia; Wu, Dan; Yuan, Yuan; Li, Xiaoran; Holm, Ruth & Tropé, Claes Gøran [Vis alle 8 forfattere av denne artikkelen] (2014). CD117 Expression in fibroblasts-like stromal cells indicates unfavorable clinical outcomes in ovarian carcinoma patients. PLOS ONE. ISSN 1932-6203. 9(11). doi: 10.1371/journal.pone.0112209.
  • Wu, Qinghua; Shi, Huirong; Holm, Ruth; Li, Xiaoran; Tropé, Claes Gøran & Nesland, Jahn M [Vis alle 7 forfattere av denne artikkelen] (2014). Aldehyde dehydrogenase-1 predicts favorable prognosis in patients with vulvar squamous cell carcinoma. Anticancer Research. ISSN 0250-7005.
  • Davidson, Ben; Tropé, Claes Gøran & Reich, Reuven (2014). The clinical and diagnostic role of microRNAs in ovarian carcinoma. Gynecologic Oncology. ISSN 0090-8258. 133(3), s. 640–646. doi: 10.1016/j.ygyno.2014.03.575.
  • Davidson, Ben; Nymoen, Dag Andre; Elgaaen, Bente Vilming; Staff, Anne Cathrine; Tropé, Claes Gøran & Kærn, Janne [Vis alle 8 forfattere av denne artikkelen] (2014). BUB1 mRNA is significantly co-expressed with AURKA and AURKB mRNA in advanced-stage ovarian serous carcinoma. Virchows Archiv. ISSN 0945-6317. 464(6), s. 701–707. doi: 10.1007/s00428-014-1577-7.
  • Vaksman, Olga; Tropé, Claes Gøran; Davidson, Ben & Reich, Reuven (2014). Exosome-derived miRNAs and ovarian carcinoma progression. Carcinogenesis. ISSN 0143-3334. 35(9), s. 2113–2120. doi: 10.1093/carcin/bgu130.
  • Davidson, Ben; Rosenfeld, Yifat B.Z.; Holth, Arild; Hellesylt, Ellen; Tropé, Claes Gøran & Reich, Reuven [Vis alle 7 forfattere av denne artikkelen] (2014). VICKZ2 protein expression in ovarian serous carcinoma effusions is associated with poor survival. Human Pathology. ISSN 0046-8177. 45(7), s. 1520–1528. doi: 10.1016/j.humpath.2014.03.005.
  • Micci, Francesca; Panagopoulos, Ioannis; Thorsen, Jim; Davidson, Ben; Tropé, Claes Gøran & Heim, Sverre (2014). Low Frequency of ESRRA-C11orf20 Fusion Gene in Ovarian Carcinomas. PLoS Biology. ISSN 1544-9173. 12(2). doi: 10.1371/journal.pbio.1001784.
  • Smebye, Marianne Lislerud; Sveen, Anita; Haugom, Lisbeth; Davidson, Ben; Tropé, Claes Gøran & Lothe, Ragnhild A [Vis alle 9 forfattere av denne artikkelen] (2014). Chromosome 19 rearrangements in ovarian carcinomas: Zinc finger genes are particularly targeted. Genes, Chromosomes and Cancer. ISSN 1045-2257. 53(7), s. 558–567. doi: 10.1002/gcc.22166.
  • Popova, Olesya; Gershenson, D.M.; Tropé, Claes Gøran; Rokkones, Erik; Sun, C.C. & Weedon-Fekjær, Harald [Vis alle 7 forfattere av denne artikkelen] (2014). Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010). European Journal of Cancer. ISSN 0959-8049. 50(11), s. 1942–1950. doi: 10.1016/j.ejca.2014.03.288.
  • Davidson, Ben; Tropé, Claes Gøran & Reich, Reuven (2014). The role of the tumor stroma in ovarian cancer. Frontiers in Oncology. ISSN 2234-943X. 4 MAY. doi: 10.3389/fonc.2014.00104.
  • Stavnes, Helene Tuft; Nymoen, Dag Andre; Hetland, Thea Eline; Kærn, Janne; Tropé, Claes Gøran & Davidson, Ben (2014). APOA1 mRNA expression in ovarian serous carcinoma effusions is a marker of longer survival. American Journal of Clinical Pathology. ISSN 0002-9173. 142(1), s. 51–57. doi: 10.1309/AJCPD8NBSHXRXQL7.
  • Micci, Francesca; Haugom, Lisbeth; Abeler, Vera Maria; Davidson, Ben; Tropé, Claes Gøran & Heim, Sverre (2014). Genomic profile of ovarian carcinomas. BMC Cancer. ISSN 1471-2407. 14(1). doi: 10.1186/1471-2407-14-315.
  • Paulsen, Torbjørn; Szczesny, Witold; Kærn, Janne; Vistad, Ingvild & Tropé, Claes Gøran (2013). Improved 8-year survival for patients with stage IIIC ovarian cancer operated on at teaching hospitals: Population-based study in Norway 2002. Clinical ovarian & other gynecologic cancer. ISSN 2212-9553. 5(2), s. 60–66. doi: 10.1016/j.cogc.2012.12.002.
  • Fehm, Tanja; Banys, Malgorzata; Rack, Brigitte; Janni, Wolfgang; Marth, Christian & Blassl, Christina [Vis alle 13 forfattere av denne artikkelen] (2013). Pooled analysis of the prognostic relevance of disseminated tumor cells in the bone marrow of patients with ovarian cancer. International Journal of Gynecological Cancer. ISSN 1048-891X. 23(5), s. 839–845. doi: 10.1097/IGC.0b013e3182907109.
  • Eriksson, Ane Gerda Zahl; Tropé, Claes Gøran; Kærn, Janne & Davidson, Ben (2013). A multidisciplinary approach to dagnosis and treatment of borderline ovarian tumors. I Odunsi, K; Pejovic, T & Thomas, C. (Red.), Gynecologic Cancers. A Multidisciplinary Approach to Diagnosis and Management. Demos Medical Publishing. ISSN 9781936287895.
  • Onsrud, Mathias; Småstuen, Milada Cvancarova; Hellebust, Taran Paulsen; Kristensen, Gunnar S Balle; Tropé, Claes Gøran & Lindemann, Kristina (2013). Long-Term Outcomes After Pelvic Radiation for Early-Stage Endometrial Cancer. Journal of Clinical Oncology. ISSN 0732-183X. 31(31), s. 3951–3956. doi: 10.1200/JCO.2013.48.8023.
  • Dhakal, Hari Prasad; Nesland, Jahn M; Førsund, Mette S; Tropé, Claes Gøran & Holm, Ruth (2013). Primary Tumor Vascularity, HIF-1α and VEGF expression in vulvar squamous cell carcinomas: their relationships with clinicopathological characteristics and prognostic impact. BMC Cancer. ISSN 1471-2407. 13(506), s. 1361–1368. doi: 10.1186/1471-2407-13-506.
  • Huang, Ruixia; Ma, Yuanyuan; Holm, Ruth; Tropé, Claes Gøran; Nesland, Jahn M & Suo, Zhenhe (2013). Sex hormone-binding globulin (SHBG) expression in ovarian carcinomas and its clinicopathological associations. PLOS ONE. ISSN 1932-6203. 8(12:e83238). doi: 10.1371/journal.pone.0083238.
  • Davidson, Ben; Smith, Yoav; Nesland, Jahn M; Kærn, Janne; Reich, Reuven & Tropé, Claes Gøran (2013). Defining a prognostic marker panel for patients with ovarian serous carcinoma effusion. Human Pathology. ISSN 0046-8177. 44(11), s. 2449–2460. doi: 10.1016/j.humpath.2013.06.003.
  • Vaksman, Olga; Davidson, Ben; Tropé, Claes Gøran & Reich, Reuven (2013). Calreticulin expression is reduced in high-grade ovarian serous carcinoma effusions compared with primary tumors and solid metastases. Human Pathology. ISSN 0046-8177. 44(12), s. 2677–2683. doi: 10.1016/j.humpath.2013.07.009.
  • Solheim, Olesya; Kærn, Janne; Tropé, Claes Gøran; Rokkones, Erik; Dahl, Alv A & Nesland, Jahn M [Vis alle 7 forfattere av denne artikkelen] (2013). Malignant ovarian germ cell tumors: Presentation, survival and second cancer in a population based Norwegian cohort (1953-2009). Gynecologic Oncology. ISSN 0090-8258. 131(2), s. 330–335. doi: 10.1016/j.ygyno.2013.08.028.
  • Magnussen, Gry Irene; Hellesylt, Ellen; Nesland, Jahn M; Tropé, Claes Gøran; Flørenes, Vivi Ann & Holm, Ruth (2013). High expression of wee1 is associated with malignancy in vulvar squamous cell carcinoma patients. BMC Cancer. ISSN 1471-2407. 13. doi: 10.1186/1471-2407-13-288.
  • Holm, Ruth; Førsund, Mette S; Nguyen, Mai; Nesland, Jahn M & Tropé, Claes Gøran (2013). Expression of p15(INK4b) and p57(KIP2) and Relationship with Clinicopathological Features and Prognosis in Patients with Vulvar Squamous Cell Carcinoma. PLOS ONE. ISSN 1932-6203. 8(4). doi: 10.1371/journal.pone.0061273.
  • Stavnes, Helene Tuft; Holth, Arild; Kærn, Janne; Don, Trinh; Vaksman, Olga & Reich, Reuven [Vis alle 8 forfattere av denne artikkelen] (2013). HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival. Gynecologic Oncology. ISSN 0090-8258. 129(2), s. 358–363. doi: 10.1016/j.ygyno.2013.02.021.
  • Micci, Francesca; Panagopoulos, Ioannis; Haugom, Lisbeth; Dahlback, Hanne-Sofie Spenning; Pretorius, Maria & Davidson, Ben [Vis alle 10 forfattere av denne artikkelen] (2013). Genomic aberration patterns and expression profiles of squamous cell carcinomas of the vulva. Genes, Chromosomes and Cancer. ISSN 1045-2257. 52(6), s. 551–563. doi: 10.1002/gcc.22053.
  • Hetland, Thea Eline; Nymoen, Dag Andre; Holth, Arild; Brusegard, Kjersti; Flørenes, Vivi Ann & Kærn, Janne [Vis alle 8 forfattere av denne artikkelen] (2013). Aurora B expression in metastatic effusions from advanced-stage ovarian serous carcinoma is predictive of intrinsic chemotherapy resistance. Human Pathology. ISSN 0046-8177. 44(5), s. 777–785. doi: 10.1016/j.humpath.2012.08.002.
  • Fotopoulou, Christina; Zang, Rongyu; Gultekin, Murat; Cibula, David; Ayhan, Ali & Liu, Dongli [Vis alle 17 forfattere av denne artikkelen] (2013). Value of Tertiary Cytoreductive Surgery in Epithelial Ovarian Cancer: An International Multicenter Evaluation. Annals of Surgical Oncology. ISSN 1068-9265. 20(4), s. 1348–1354. doi: 10.1245/s10434-012-2673-z.
  • Davidson, Ben; Holth, Arild; Nguyen, Mai; Tropé, Claes Gøran & Wu, Chuanyue (2013). Migfilin, alpha-parvin and beta-parvin are differentially expressed in ovarian serous carcinoma effusions, primary tumors and solid metastases. Gynecologic Oncology. ISSN 0090-8258. 128(2), s. 364–370. doi: 10.1016/j.ygyno.2012.10.015.
  • Weiss, Ilana; Tropé, Claes Gøran; Reich, Reuven & Davidson, Ben (2012). Hyaluronan Synthase and Hyaluronidase Expression in Serous Ovarian Carcinoma is Related to Anatomic Site and Chemotherapy Exposure. International Journal of Molecular Sciences. ISSN 1661-6596. 13(10), s. 12925–12938. doi: 10.3390/ijms131012925.
  • Vaksman, Olga; Hetland, Thea Eline; Tropé, Claes Gøran; Reich, Reuven & Davidson, Ben (2012). Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma. Human Pathology. ISSN 0046-8177. 43(11), s. 2062–2069. doi: 10.1016/j.humpath.2012.02.016.
  • Hetland, Thea Eline; Kærn, Janne; Skrede, Martina; Sandstad, Berit; Tropé, Claes Gøran & Davidson, Ben [Vis alle 7 forfattere av denne artikkelen] (2012). Predicting platinum resistance in primary advanced ovarian cancer patients with an in vitro resistance index. Cancer Chemotherapy and Pharmacology. ISSN 0344-5704. 69(5), s. 1307–1314. doi: 10.1007/s00280-012-1835-9.
  • Hetland, Thea Eline; Nymoen, Dag Andre; Emilsen, Elisabeth; Kærn, Janne; Tropé, Claes Gøran & Flørenes, Vivi Ann [Vis alle 7 forfattere av denne artikkelen] (2012). MGST1 expression in serous ovarian carcinoma differs at various anatomic sites, but is unrelated to chemoresistance or survival. Gynecologic Oncology. ISSN 0090-8258. 126(3), s. 460–465. doi: 10.1016/j.ygyno.2012.05.029.
  • Tropé, Claes Gøran; Elstrand, Mari Bunkholt; Sandstad, Berit; Davidson, Ben & Oksefjell, Halldis (2012). Neoadjuvant chemotherapy, interval debulking surgery or primary surgery in ovarian carcinoma FIGO stage IV? European Journal of Cancer. ISSN 0959-8049. 48(14), s. 2146–2154. doi: 10.1016/j.ejca.2012.01.031.
  • Liang, Dongming; Ma, Yuanyuan; Liu, Jian; Tropé, Claes Gøran; Holm, Ruth & Nesland, Jahn M [Vis alle 7 forfattere av denne artikkelen] (2012). The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells. BMC Cancer. ISSN 1471-2407. 12. doi: 10.1186/1471-2407-12-201.
  • Pradhan, Manohar; Davidson, Ben; Abeler, Vera Maria; Danielsen, Håvard Emil; Tropé, Claes Gøran & Kristensen, Gunnar S Balle [Vis alle 7 forfattere av denne artikkelen] (2012). DNA ploidy may be a prognostic marker in stage I and II serous adenocarcinoma of the endometrium. Virchows Archiv. ISSN 0945-6317. 461(3), s. 291–298. doi: 10.1007/s00428-012-1275-2.
  • Tropé, Claes Gøran; Kærn, Janne & Davidson, Ben (2012). Borderline ovarian tumours. Best Practice & Research: Clinical Obstetrics & Gynaecology. ISSN 1521-6934. 26(3), s. 325–336. doi: 10.1016/j.bpobgyn.2011.12.006.
  • Tropé, Claes Gøran; Abeler, Vera Maria & Kristensen, Gunnar S Balle (2012). Diagnosis and treatment of sarcoma of the uterus. A review. Acta Oncologica. ISSN 0284-186X. 51(6), s. 694–705. doi: 10.3109/0284186X.2012.689111.
  • Hetland, Thea Eline; Holth, Arild; Kærn, Janne; Flørenes, Vivi Ann; Tropé, Claes Gøran & Davidson, Ben (2012). HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases. Virchows Archiv. ISSN 0945-6317. 460(5), s. 505–513. doi: 10.1007/s00428-012-1228-9.
  • Brusegard, Kjersti; Stavnes, Helene Tuft; Nymoen, Dag Andre; Flatmark, Kjersti; Tropé, Claes Gøran & Davidson, Ben (2012). Rab25 is overexpressed in Mullerian serous carcinoma compared to malignant mesothelioma. Virchows Archiv. ISSN 0945-6317. 460(2), s. 193–202. doi: 10.1007/s00428-011-1191-x.
  • Elstrand, Mari Bunkholt; Sandstad, Berit; Oksefjell, Halldis; Davidson, Ben & Tropé, Claes Gøran (2012). Prognostic significance of residual tumor in patients with epithelial ovarian carcinoma stage IV in a 20 year perspective. Acta Obstetricia et Gynecologica Scandinavica. ISSN 0001-6349. 91(3), s. 308–317. doi: 10.1111/j.1600-0412.2011.01316.x.
  • Bock, Annika Jøntvedt; Dong, Phuc Hiep; Tropé, Claes Gøran; Staff, Anne Cathrine; Risberg, Bjørn Åke & Davidson, Ben (2012). Nucleoside transporters are widely expressed in ovarian carcinoma effusions. Cancer Chemotherapy and Pharmacology. ISSN 0344-5704. 69(2), s. 467–475. doi: 10.1007/s00280-011-1716-7.
  • Elstrand, Mari Bunkholt; Stavnes, Helene Tuft; Tropé, Claes Gøran & Davidson, Ben (2012). Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions. Human Pathology. ISSN 0046-8177. 43(4), s. 529–535. doi: 10.1016/j.humpath.2011.05.022.
  • Brenne, Kjersti; Nymoen, Dag Andre; Hetland, Thea Eline; Tropé, Claes Gøran & Davidson, Ben (2012). Expression of the Ets transcription factor EHF in serous ovarian carcinoma effusions is a marker of poor survival. Human Pathology. ISSN 0046-8177. 43(4), s. 496–505. doi: 10.1016/j.humpath.2011.05.023.
  • Tian, Wen-Juan; Chi, Dennis S.; Sehouli, Jalid; Tropé, Claes Gøran; Jiang, Rong & Ayhan, Ali [Vis alle 18 forfattere av denne artikkelen] (2012). A Risk Model for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer: An Evidence-Based Proposal for Patient Selection. Annals of Surgical Oncology. ISSN 1068-9265. 19(2), s. 597–604. doi: 10.1245/s10434-011-1873-2.
  • Pradhan, Manohar; Abeler, Vera Maria; Danielsen, Håvard Emil; Sandstad, Berit; Tropé, Claes Gøran & Kristensen, Gunnar S Balle [Vis alle 7 forfattere av denne artikkelen] (2012). Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium. Annals of Oncology. ISSN 0923-7534. 23(5), s. 1178–1184. doi: 10.1093/annonc/mdr368.
  • Davidson, Ben; Tropé, Claes Gøran & Reich, Reuven (2012). Epithelial-mesenchymal transition in ovarian carcinoma. Frontiers in Oncology. ISSN 2234-943X. 2. doi: 10.3389/fonc.2012.00033.
  • Gillet, Jean-Pierre; Wang, Junbai; Calcagno, Anna Maria; Green, Lisa J.; Varma, Sudhir & Elstrand, Mari Bunkholt [Vis alle 10 forfattere av denne artikkelen] (2011). Clinical relevance of multidrug resistance gene expression in ovarian serous carcinoma effusions. Molecular Pharmaceutics. ISSN 1543-8384. 8(6), s. 2080–2088. doi: 10.1021/mp200240a.
  • Dong, Phuc Hiep; Rosnes, Anne Katrine Ree; Bock, Annika Jøntvedt; Holth, Arild; Flørenes, Vivi Ann & Tropé, Claes Gøran [Vis alle 8 forfattere av denne artikkelen] (2011). Flow cytometric measurement of cellular FLICE-inhibitory protein (c-FLIP) in ovarian carcinoma effusions. Cytopathology. ISSN 0956-5507. 22(6), s. 373–382. doi: 10.1111/j.1365-2303.2011.00929.x.
  • Zang, R. Y.; Harter, P.; Chi, D. S.; Sehouli, J; Jiang, R & Tropé, Claes Gøran [Vis alle 18 forfattere av denne artikkelen] (2011). Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort. British Journal of Cancer. ISSN 0007-0920. 105(7), s. 890–896. doi: 10.1038/bjc.2011.328.
  • Wang, Zhihui; Nesland, Jahn M; Suo, Zhenhe; Tropé, Claes Gøran & Holm, Ruth (2011). The Prognostic Value of 14-3-3 Isoforms in Vulvar Squamous Cell Carcinoma Cases: 14-3-3 beta and epsilon Are Independent Prognostic Factors for These Tumors. PLOS ONE. ISSN 1932-6203. 6(9). doi: 10.1371/journal.pone.0024843.
  • Davidson, Ben; Holth, Arild; Moripen, Leni Tøndevold; Tropé, Claes Gøran & Shih, Ie-Ming (2011). Osteopontin expression in ovarian carcinoma effusions is related to improved clinical outcome. Human Pathology. ISSN 0046-8177. 42(7), s. 991–997. doi: 10.1016/j.humpath.2010.10.013.
  • Yuan, Yuan; Leszczynska, Magdalena; Konstantinovsky, Sophya; Tropé, Claes Gøran; Reich, Reuven & Davidson, Ben (2011). Netrin-4 Is Upregulated in Breast Carcinoma Effusions Compared to Corresponding Solid Tumors. Diagnostic Cytopathology. ISSN 8755-1039. 39(8), s. 562–566. doi: 10.1002/dc.21424.
  • Oksefjell, Halldis; Sandstad, Berit & Tropé, Claes Gøran (2011). The role of surgery in the second relapse of epithelial ovarian cancer. Selection criteria, morbidity and survival outcome. European Journal of Gynaecological Oncology. ISSN 0392-2936. 32(4), s. 369–376.
  • Vaksman, Olga; Stavnes, Helene Tuft; Kærn, Janne; Tropé, Claes Gøran; Davidson, Ben & Reich, Reuven (2011). miRNA profiling along tumour progression in ovarian carcinoma. Journal of Cellular and Molecular Medicine. ISSN 1582-1838. 15(7), s. 1593–1602. doi: 10.1111/j.1582-4934.2010.01148.x.
  • Paulsen, Torbjørn; Kærn, Janne & Tropé, Claes Gøran (2011). Improved 5-year disease-free survival for FIGO stage I epithelial ovarian cancer patients without tumor rupture during surgery. Gynecologic Oncology. ISSN 0090-8258. 122(1), s. 83–88. doi: 10.1016/j.ygyno.2011.02.038.
  • Hetland, Thea Eline; Hellesylt, Ellen; Flørenes, Vivi Ann; Tropé, Claes Gøran; Davidson, Ben & Kærn, Janne (2011). Class III beta-tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance. Human Pathology. ISSN 0046-8177. 42(7), s. 1019–1026. doi: 10.1016/j.humpath.2010.10.025.

Se alle arbeider i Cristin

  • Solheim, Olesya; Dahl, Alv A; Nesland, Jahn M; Kærn, Janne; Tropé, Claes Gøran & Rokkones, Erik [Vis alle 7 forfattere av denne artikkelen] (2013). Malignant germ cell ovarian cancer (MGCOC) in the Cancer Registry of Norway (CRN): A long-term follow-up study of presentation, survival, and second cancers. Journal of Clinical Oncology. ISSN 0732-183X. 31.
  • Szczesny, Witold; Paulsen, Torbjørn; Vistad, Ingvild; Nakling, Jakob; Sandvik, Leiv & Tropé, Claes Gøran (2012). The impact of first- and second line treatment on survival and recurrence free survival of patients with advanced epithelial ovarian cancer treated at Teaching Hospitals versus Non-Teaching Hospitals in Norway. Acta Obstetricia et Gynecologica Scandinavica. ISSN 0001-6349. 91, s. 131–132.
  • Lindemann, Kristina; Onsrud, Mathias; Kristensen, Gunnar S Balle & Tropé, Claes Gøran (2012). Survival after radiation therapy for early-stage endometrial carcinoma: The Oslo study revisited after up to 43 years of follow-up. Journal of Clinical Oncology. ISSN 0732-183X. 30(15).
  • Vaksman, Olga; Davidson, Ben; Tropé, Claes Gøran & Reich, R (2012). Unique MiRNA Signature and Oncogenic Potential of Effusion Fluid-derived Exosomes From Ovarian Carcinoma Patients. European Journal of Cancer. ISSN 0959-8049. 48, s. S93–S94.
  • Vergote, Ignace; Tropé, Claes Gøran; Amant, Frédéric; Ehlen, Tom; Reed, Nick S. & Casado, Antonio (2011). Neoadjuvant Chemotherapy Is the Better Treatment Option in Some Patients With Stage IIIc to IV Ovarian Cancer. Journal of Clinical Oncology. ISSN 0732-183X. 29(31), s. 4076–4078. doi: 10.1200/JCO.2011.36.9785.

Se alle arbeider i Cristin

Publisert 28. aug. 2015 11:14 - Sist endret 28. aug. 2015 11:14